Essential role for ERK mitogen-activated protein kinase in matrix metalloproteinase-9 regulation in rat cortical astrocytes

GLIA

Volumn 43, Issue 3, 2003, Pages 254-264

  Arai, Ken ^a,b   Lee, Sun Ryung ^a   Lo, Eng H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Astrocytes; Edema; Hemorrhage; Matrix metalloprotease 9; Mitogen activated protein kinase; Neuroprotection

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CYTOKINE; GELATINASE A; GELATINASE B; JANUS KINASE; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASTROCYTE; BRAIN CORTEX; BRAIN INJURY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME PHOSPHORYLATION; ENZYME RELEASE; IMMUNOCYTOCHEMISTRY; INFLAMMATION; NONHUMAN; NORTHERN BLOTTING; RAT; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; ZYMOGRAPHY;

ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; BIOLOGICAL MARKERS; CELLS, CULTURED; CEREBRAL CORTEX; ENZYME INHIBITORS; IMMUNOHISTOCHEMISTRY; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MATRIX METALLOPROTEINASE 9; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0041363324     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.10255     Document Type: Article

References (41)

1. Abe K, Saito H. 2000. L-glutamate suppresses amyloid beta-protein-induced stellation of cultured rat cortical astrocytes. J Neurochem 74:280-286.
2. Asahi M, Asahi K, Jung JC, del Zoppo GJ, Fini ME, Lo EH. 2000. Role of matrix metalloproteinase 9 in focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab 20:1681-1690.
3. Asahi M, Wang X, Mori T, Sumii T, Jung JC, Moskowitz MA, Fini ME, Lo EH. 2001. Effects of matrix metalloproteinase-9 gene knockout on the proteolysis of blood-brain barrier and white matter components after focal cerebral ischemia. J Neurosci 21:7724-7732.
4. Cross AK, Woodroofe MN. 1999. Chemokine modulation of matrix metalloproteinase and TIMP production in adult rat brain microglia and a human microglial cell line in vitro. Glia 28:183-189.
5. Dubois B, Masure S, Hurtenbach U, Paemen L, Heremans H, van den Oord J, Sciot R, Meinhardt T, Hammerling G, Opdenakker G, Arnold B. 1999. Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions, J Clin Invest 104:1507-1515.
6. Ferguson TA, Muir D. 2000. MMP-2 and MMP-9 increase the neurite-promoting potential of schwann cell basal laminae and are upregulated in degenerated nerve. Mol Cel Neurosci 16:157-167.
7. Fini ME, Cook JR, Mohan R, Brinkerhoff CE. 1998. Regulation of matrix metalloproteinase gene expression. In: Parks WC, Mecham RP, editors. Matrix metalloproteinases. New York: Academic Press. p 299-356.
8. Gasche Y, Fujimura Y, Copin J, Kawase M, Masengale J, Chan PH, 1999. Early appearance of activated MMP-9 after focal cerebral ischemia in mice. J Cereb Blood Flow Metab 19:1020-1028.
9. Gasche Y, Copin JC, Sugawara T, Fujimura M, Chan PH. 2001. Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia. J Cereb Blood Flow Metab 21:1393-1400.
10. Genersch E, Hayess K, Neuenfeld Y, Haller H. 2000. Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways. J Cell Sci 113:4319-4330.
11. Gottschall PE, Yu X, Bing B. 1995. Increased production of gelatinase B (matrix metalloproteinase-9) and interleukin-6 by activated rat microglia in culture. J Neurosci Res 42:335-432.
12. Gu Z, Kaul M, Yan B, Kridel SJ, Cui J, Strongin A, Smith JW, Liddington RC, Lipton SA. 2002. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 297:1186-1190.
13. Gum R, Lengyel E, Juarez J, Chen JH, Sato H, Seiki M, Boyd D. 1996. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J Biol Chem 271:10672-10680.
14. Gurjar MV, Deleon J, Sharma RV, Bhalla RC. 2001. Role of reactive oxygen species in IL-1 beta-stimulated sustained ERK activation and MMP-9 induction. Am J Physiol Heart Circ Physiol 281: H2568-H2574.
15. Hartung HP, Kieseier BC. 2000. The role of matrix metalloproteases in autoimmune damage to the central and peripheral nervous system. J Neuroimmunol 107:140-147.
16. Heo JH, Lucero J, Abumiya T, Koizol JA, Copeland BR, del Zoppo GJ. 1999. Matrix metalloproteinases increase very early during exper-imental focal cerebral ischemia. J Cereb Blood Flow Metab 19:624-633.
17. Kolch W, Heidecker G, Kochs G, Hummel R, Vahidi H, Mischak H, Finkenzeller G, Marme D, Rapp UR. 1993. Protein kinase C alpha activates RAF-1 by direct phosphorylation. Nature 364:249-252.
18. Lo EH, Wang X, Cuzner ML. 2002. Extracellular proteolysis in brain injury and inflammation: role for plasminogen activators and matrix metalloproteinases. J Neurosci Res 69:1-9.
19. Lukashev ME, Werb Z. 1998. ECM signaling: orchestrating cell behavior and misbehavior. Trends Cell Biol 8:437-441.
20. Marquardt B, Frith D, Stabel S. 1994. Signalling from TPA to MAP kinase requires protein kinase C, raf and MEK: reconstitution of the signaling pathway in vitro. Oncogene 9:3213-3218.
21. Mori T, Wang X, Aoki T, Lo EH. 2002. Downregulation of matrix metalloproteinase-9 and attenuation of edema via inhibition of ERK mitogen activated protein kinase in traumatic brain injury. J Neurotrauma 19:1411-1419.
22. Morita-Fujimura Y, Fujimura M, Gasche Y, Copin J, Chan PH. 1999. Overexpression of copper and zinc superoxide dismutase in transgenic mice prevents the induction and activation of matrix metalloproteinases after cold injury induced brain trauma. J Cereb Blood Flow Metab 20:130-138.
23. Muir EM, Adcock KH, Morgenstern DA, Clayton R, von Stillfried N, Rhodes K, Ellis C, Fawcett JW, Rogers JH. 2002. Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes. Brain Res Mol Brain Res 100:103-117.
24. Mun-Bryce S, Rosenberg GA. 1998. Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. Am J Physiol 274: R1203-R1211.
25. Murphy LO, Smith S, Chen RH, Fingar DC, Blenis J. 2002. Molecular interpretation of ERK signal duration by immediate early gene products. Nat Cell Biol 4:556-564.
26. Nagase H, Woessner JF. 1999. Matrix metalloproteinases. J Biol Chem 274:21491-21494.
27. Nygardas PT, Hinkkanen AE. 2002. Up-regulation of MMP-8 and MMP-9 activity in the BALB/c mouse spinal cord correlates with the severity of experimental autoimmune encephalomyelitis. Clin Exp Immunol 128:245-254.
28. Planas AM, Justicia C, Sole S, Friguls B, Cervera A, Adell A, Chamorro A. 2002. Certain forms of matrix metalloproteinase-9 accumulate in the extracellular space after microdialysis probe implantation and middle cerebral artery occlusion/reperfusion. J Cereb Blood Flow Metab 22:918-925.
29. Rosenberg GA, Navratil M. 1997. Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat. Neurology 48:921-926.
30. Rosenberg GA, Cunningham LA, Wallace J, Alexander S, Estrada EY, Grossetete M, Razhagi A, Miller K, Gearing A. 2001. Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res 893:104-1012.
31. Rosenberg GA. 2002. Matrix metalloproteinases in neuroinflammation. Glia 39:279-291.
32. Simon C, Goepfert H, Boyd D. 1998. Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion. Cancer Res 58:1135-1139.
33. Shin M, Yan C, Boyd D. 2002. An inhibitor of c-jun aminoterminal kinase (SP600125) represses c-Jun activation, DNA-binding and PMA-inducible 92-kDa type IV collagenase expression. Biochim Biophys Acta 1589:311-316.
34. Sumii T, Lo EH. 2002. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats. Stroke 33:831-836.
35. Ueda Y, Hirai S, Osada S, Suzuki A, Mizuno K, Ohno S. 1996. Protein kinase C activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf. J Biol Chem 271:23512-23519.
36. Vecil GG, Larsen PH, Corley SM, Herx LM, Besson A, Goodyer CG, Yong VW. 2000. Interleukin-1 is a key regulator of matrix metalloproteinase-9 expression in human neurons in culture and following mouse brain trauma in vivo. J Neurosci Res 61:212-224.
37. Wang X, Jung J, Asahi M, Chwang W, Russo L, Moskowitz MA, Dixon CE, Fini ME, Lo EH. 2000. Effects of matrix metalloproteinase 9 gene knockout on morphological and motor outcomes after traumatic brain injury. J Neurosci 20:7037-7043.
38. Wang X, Mori T, Jung JC, Fini ME, Lo EH. 2002. Secretion of matrix metalloproteinase-2 and -9 after mechanical trauma injury in rat cortical cultures and involvement of MAP kinase. J Neurotrauma 19:615-625.
39. Yong VW, Power C, Forsyth PA, Edwards DR. 2001. Metalloproteinases in biology and pathology of the nervous system. Nat Neurosci Rev 2:502-511.
40. Zhang JW, Gottschall PE. 1997. Zymographic measurement of gelatinase activity in brain tissue after detergent extraction and affinity-support purification. J Neurosci Methods 76:15-20.
41. Zhang JW, Deb S, Gottschall PE. 1998. Regional and differential expression of gelatinases in rat brain after systemic kainic acid or bicuculline administration. Eur J Neurosci 10:3358-3368.